Creative Medical Technology Holdings, Inc. Common StockCELZ

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) is a clinical-stage biotechnology company pioneering regenerative medicine therapies derived from adult and perinatal stem cell technologies. The Company's pipeline targets large, underserved markets across orthopedics, immunotherapy, endocrinology, urology, and gynecology, with CELZ-201 (Olastrocel) positioned as a lead clinical asset for chronic lower back pain and as the backbone for additional platform.

creativemedicaltechnology.com